Discontinued — last reported Q4 '24

Tax

Tax Reconciliation - Tax Exempt Income

Vertex Pharmaceuticals Tax Reconciliation - Tax Exempt Income remained flat by 0.0% to $0.00 in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 94.9%, from $0.06 to $0.00. Over 2 years (FY 2023 to FY 2025), Tax Reconciliation - Tax Exempt Income shows an upward trend with a 27.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement
SectionTax
CategoryProfitability
SignalHigher is better
VolatilityStable
First reportedQ1 2014
Last reportedQ4 2024

How to read this metric

Higher values suggest more efficient tax planning or a higher concentration of tax-exempt investments.

Detailed definition

This metric quantifies the tax savings derived from income sources that are explicitly exempt from taxation under curren...

Peer comparison

Standard line item in tax reconciliation notes for most large-cap corporations.

Metric ID: is_ms_tax_reconciliation_tax_exempt_income

Historical Data

3 years
 FY'23FY'24FY'25
Value$0.01$0.26$0.01
YoY Change—>999%-94.9%
Range$0.01 – $0.26
CAGR+27.5%
Avg YoY Growth>999%
Median YoY Growth>999%

Frequently Asked Questions

What is Vertex Pharmaceuticals's tax reconciliation - tax exempt income?
Vertex Pharmaceuticals (VRTX) reported tax reconciliation - tax exempt income of $0.00 in Q4 2025.
How has Vertex Pharmaceuticals's tax reconciliation - tax exempt income changed year-over-year?
Vertex Pharmaceuticals's tax reconciliation - tax exempt income decreased by 94.9% year-over-year, from $0.06 to $0.00.
What is the long-term trend for Vertex Pharmaceuticals's tax reconciliation - tax exempt income?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's tax reconciliation - tax exempt income has grown at a 27.5% compound annual growth rate (CAGR), from $0.01 to $0.01.
What does tax reconciliation - tax exempt income mean?
The tax savings realized from income that is not subject to taxation.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.